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Abstract Myxoinflammatory fibroblastic sarcoma (MIFS)
is a rare low-grade sarcoma of the distal extremities
characterized by a myxohyaline stroma, a dense inflamma-
tory infiltrate and virocyte- and lipoblast-like giant cells. Up
to now, only two cases have been investigated cytogeneti-
cally, showing complex and heterogeneous karyotypes, in
part with supernumerary ring chromosomes. We character-
ized two further cases of MIFS immunohistochemically and
performed comparative genomic hybridization as well as
DNA image cytometry analyses. Both tumors showed the
characteristic histomorphological pattern of MIFS and were
positive for Vimentin and CD68. Moreover, both cases
presented aberrant karyotypes including distinct DNA copy
number changes involving chromosome 7 and disclosed
DNA aneuploidy.
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Introduction
In 1998, Montgomery et al. [14] first described inflamma-
tory myxohyaline tumors of the distal extremities with
virocyte or Reed-Sternberg-like cells as a distinct tumor
entity with unique histologic features. In the same year,
Meis-Kindblom et al. coined the shorter term acral
myxoinflammatory fibroblastic sarcoma (MIFS) for the
same lesion, usually presenting as poorly circumscribed
multinodular mass of the distal extremities ranging from
less than 1 to 8 cm in size [2, 12]. Patients typically report a
history of slowly growing and painless tumors that only
occasionally are associated with pain or decreased mobility
[2]. Histologically, MIFS exhibit a dense inflammatory
infiltrate, predominantly consisting of lymphocytes and
plasma cells, embedded in an alternating myxoid and
hyaline stroma. Three main types of neoplastic cells can
be distinguished, namely spindle-shaped cells, bizarre
virocyte, or ganglion-like cells with enlarged nuclei and
often huge, inclusion-like nucleoli and multinucleated
lipoblast-like cells of variable size. Tumor cells are
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dispersed through the myxohyaline stroma as single cells or
form coherent nodules [2, 9, 12–14, 17, 18]. The rates of
local recurrences range between 22 and 67%, probably
depending on differences in surgical treatment, whereas
distant metastases are exceedingly rare (<2% of all reported
cases) [2, 12, 14, 17].
Cytogenetic data on chromosomal aberrations of MIFS
are scarce, and up to now, only two cases have been
investigated so far. One of them revealed a complex
karyotype with a reciprocal translocation t(1;10)(p22;q24)
in addition to the loss of chromosome 3 and 13, while the
other exhibited supernumerary ring chromosomes and a
derivate chromosome 13 with additional material on the
short arm [9, 11]. In this paper, we report two further cases
of MIFS investigated by immunohistochemistry, compara-




The biopsy specimens were formalin-fixed, routinely pro-
cessed, paraffin-embedded, and stained with hematoxylin
and eosin. The panel of applied primary antibodies,
dilutions, and different methods of tissue preparation and
pretreatment, respectively, are listed in Table 1. All primary
antibodies were diluted in a 1% solution of bovine serum
albumin in phosphate-buffered saline (pH 7.4) and incu-
bated for 30 min at room temperature. After incubation
with the biotinylated secondary antibody, the avidin–
biotin–peroxidase complex was applied for 30 min, and
color development was performed using diamino-benzidine
(DAB). The slides were counterstained with hemalaun,
dehydrated, and mounted.
Comparative genomic hybridization
For CGH, tumor DNA was isolated from formalin-fixed and
deparaffinized tumor tissue by proteinase K digestion (2mg/ml
final concentration; Roche, Mannheim, Germany) followed by
spin column purification (Qiagen, Hilden, Germany). Labeling
of tumor DNA with biotin-16-dUTP (Roche, Mannheim,
Germany) and normal reference DNA with digoxigenin-
11-dUTP (Roche) was performed by standard nick translation.
The denatured DNA probe containing 2 μg of tumor DNA,
1.5 μg of reference DNA, and 80 μg of COT-1 DNA was
hybridized for 3 days to normal metaphase spreads on glass
slides (15×15 mm cover glass area). The slides were then
washed, blocked with bovine serum albumin solution, and
incubated with fluorescein-conjugated avidin (Vector Labora-
tories, Burlingame, CA) and rhodamine-conjugated antidigox-
igenin (Roche). Finally, the slides were washed and mounted
in antifade solution (Vector Laboratories) containing 2.5 μg/ml
of 4,6-diamino-2-phenylindole (DAPI) counterstain. Image
acquisition was performed on a Zeiss Axioskop fluorescence
microscope (Zeiss, Göttingen, Germany) equipped with three
separate bandpass filters (DAPI bandpass, Green single
bandpass, Red single bandpass) and a high sensitive mono-
chrome charge coupled device camera (Photometrics, Tuscon,
AZ). For each analysis, the averaged chromosome-specific
green to red fluorescence ratios and their 95% confidence
intervals (CI) from at least ten well-selected metaphases were
plotted using the Quips CGH software (distributed through
Applied Imaging, Newcastle, UK). Relative copy number
changes were interpreted as gains when the average green-
to-red ratio exceeded 1.2 or 2 (high-level amplification), and
Table 1 Antibodies used in the study
Antibody specificity Source Type Dilution Pretreatment
Vimentin Novocastra (Nunningen, Switzerland) mm 1:50 Microwave
CD15 Dako Cytomation (Baar, Switzerland) mm 1:100 Microwave
CD30 Dako Cytomation (Baar, Switzerland) mm Prediluted Microwave
CD34 Dako Cytomation (Baar, Switzerland) mm 1:200 Microwave
CD68 Dako Cytomation (Baar, Switzerland) mm 1:1,600 Microwave
CK22 Biomeda (Foster City, USA) mm 1:200 Microwave
EMA Dako Cytomation (Baar, Switzerland) mm 1:1600 Microwave
Desmin Dako Cytomation (Baar, Switzerland) mm 1:4,000 Microwave
Actin NeoMarkers (Fremont, USA) mm 1:25 Microwave
SMA Dako Cytomation (Baar, Switzerland) mm Prediluted None
S100 Protein Medite (Nunningen, Switzerland) rp 1:1,600 Microwave
CD Cluster of differentiation, CK cytokeratin, EMA epithelial membrane antigen, SMA smooth muscle actin, mm mouse monoclonal, rp rabbit
polyclonal
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as losses when the corresponding ratio was less than 0.8.
Exceptionally, in cases with only trends not reaching the
aforementioned thresholds, deviations from normal were
classified as gains or losses when the 95% CI varied beyond
the ratio of 1.0. An event was defined as a gain or a loss of (part
of) a chromosomal arm. Chromosomal regions 1p32-pter, 13p,
14p, 15p, 19, 21p, 22p, telomeres and constitutive heterochro-
matic regions at 1q, 9q, 16q, and Yq reported to produce false
results by CGH were excluded from all analyses [7].
DNA image cytometry
The specimens were evaluated with the semiautomatic
AUTOCYTETM cell analytical system (Carl Zeiss AG, CH
8706 Feldmeilen) using a Zeiss AxioplanTM microscope.
On average, 135 (104–153) of the most abnormally looking
tumor cells were selected as test cells, whereas 50 nuclei of
lymphocytes were measured as internal standard.
The histograms were analyzed following the recommen-
dations of the European Society for Analytical and Cellular
Pathology (ESACP) [3, 4]. Both stemlines and single events
were considered. The key data of DNA cytometry, i.e.,
integrated optical density and nuclear area, were transferred
to the server EUROQUANTTM (http://euroquant.med.
tu-dresden.de) at the Institute of Pathology, Technical
University/Dresden, which is available free of charge to
any user for quality assurance [5]. There, the data were
standardized and evaluated on the basis of statistic models,
by which, the number of stemlines, their position on the
ploidy axis, and their coefficient of variation are deter-
mined. EUROQUANT delivers the modal DNA values of
peaks and the coefficient of variation (CV) value of
stemlines and calculates several quality parameters defined
by the ESACP (e.g., parameters for a control of measured
glare factors and of the homogeneity of measurement) and
compares them to established limit values. Single events
were directly analyzed on the basis of the AUTOCYTE
data. Ploidy classes were defined as follows: euploid/
diploid: 1.8–2.2 c; tetraploid/polyploid: 3.6–4.4 c; octa-
ploid: 7.2–8.8 c; aneuploid: stemline outside of a euploid
region (2 c, 4 c, 8 c, etc.), single events >8.8 c.
Results
Clinical findings
Clinical features of the two cases are summarized in Table 2.
One patient noticed a slowly growing painless mass in the
right index finger and was treated surgically by local excision
(case 1). The other patient suffered from pain in the right
popliteal fossa and observed a slowly growing tumor that
turned out to be located inside the tibial nerve (case 2). After
histologic diagnosis, treatment consisted in isolated limb
perfusion with tumor necrosis factor alpha (TNF-α) and
Melphalan followed by neoadjuvant percutaneous radiother-
apy and local excision without destruction of major fascicles.
On histologic examination, no viable tumor was detectable
anymore, and the patient did not sustain sensory or motor
deficits (Fig. 1). At initial surgery, both tumors showed a
myxoid aspect with no signs of necrosis or hemorrhage on
cut section. Patient 1 developed local recurrence 5 months
after initial resection and underwent re-excision followed by
another recurrence 16 months later. The second patient is still
free of disease (follow-up 14 months).
Microscopical and immunohistochemical findings
Light microscopy showed cell-rich tumors containing myx-
oid and hyaline areas and zones of fibrosis (Fig. 2). Tumor
cells revealed pronounced nuclear polymorphism, including
differences in nuclear size and form. Some cells were rather
small and spindle-shaped, while others revealed big vesic-
ular nuclei and prominent nucleoli, focally resembling
ganglion cells or virocytes (Fig. 2f). Additionally, multinu-
cleated cells and lipoblast-like cells with multiple intra-
cytoplasmatic mucin-containing vacuoles were present in all
cases (Fig. 2a–c). The inflammatory infiltrates were dense
and particularly prominent in the fibrotic and myxoid areas
of the tumors. Immunohistochemically all tumors were
strongly positive for vimentin and focally positive for
CD68 (not shown). Expression of CK22, CD15, CD30,
epithelial membrane antigen (EMA), S100 protein, or
desmin could not be detected in any of the two cases.
Table 2 Clinical features
Case Sex/age Location Size Follow-up
1 F/51 Right index finger 2×1.5×1 cm Recurrences after 5 and 16 months
2 F/75 Right popliteal fossa, tibial nerve 4×2×1.7 cm 14 months NED
NED No evidence of disease, M male, F female
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Fig. 1 a Case 2: T1-weighted
MR showing a hypointense
tumor surrounding the tibial
nerve (yellow arrows). b Case 2:
Intraoperative situation with
isolated nerve before tumor
resection (yellow arrows)
Fig. 2 a Case 1—HE×400:
multivacuolated lipoblast-like
tumor cells admixed with a
loose inflammatory infiltrate.
b Case 1—HE×400: tumor cells
are embedded in a myxohyaline
stroma. c Case 1—HE×640:
lipoblast-like tumor cells in
close contact to lymphocytes
and some eosinophils.
d Case 2—HE×200: spindle-
shaped tumor cells admixed
with a dense inflammatory
infiltrate and embedded in a
collagenous hyalinized stroma.
e Case 2—HE×200: spindle-
shaped tumor cells and lympho-
cytes in a myxoid stroma. f Case
2—HE×640: Ganglion-like tu-
mor cells with large eosinophilic
nucleoli accompanied by lym-
phocytes and plasma cells
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Comparative genomic hybridization
DNA copy number changes were identified in both cases
(Table 3, Fig. 3). The number of changes ranged from two
(case 1) to three (case 2). There were no specific common
gains or losses, but both investigated cases showed gains at
chromosome 7.
DNA image cytometry
All tumors revealed aneuploid stemlines and additional
aneuploid single events. Modal DNA value of peaks ranged
between 2.54 c and 2.72 c (mean 2.63 c). The CV varied
between 7.31 and 7.36% (mean 7.34%).
Discussion
Myxoinflammatory fibroblastic sarcomas are rare low-grade
tumors typically presenting as painless and slowly growing
masses of the distal extremities. According to the Medline
database, 133 cases have been reported up to now, including
Table 3 CGH analysis
Case Results
1 0.20: rev ish enh(3p11p12, 7q31q32)
trend enh(1p, 18), dim(6q14qter)
2 0,20: rev ish enh(5pterq32, 7p15p21, 14q12q21)
Fig. 3 a–b Comparative ge-
nomic analyses of cases 1–2
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several tumors of the proximal extremities as well (upper
arm, thigh) [1, 6, 8–10, 12–17]. Both investigated cases
revealed the characteristic histomorphological and immu-
nohistochemical pattern of MIFS. Besides the alternating
and confluencing myxoid and hyaline stroma containing a
predominantly lymphoplasmocytic inflammatory infiltrate,
all tumors exhibited intermixed spindle cells, large polyg-
onal and partially bizarre ganglion-like cells with huge
inclusion-like nucleoli and bubbly multinucleated cells
resembling lipoblasts (Fig. 2). Immunohistochemically, the
tumor cells stained positive for Vimentin and CD68.
Cytogenetic data on chromosomal aberrations on MIFS
are limited. To our knowledge, only two cases have been
investigated by conventional cytogenetic and fluorescence in
situ hybridization analyses so far. One case showed a derivate
chromosome 13 with additional material on the short arm and
supernumerary ring chromosomes, while the other exhibited
a complex karyotype with a reciprocal translocation t(1;10)
(p22;q24) and losses of chromosomes 3 and 13 [9, 11]. The
two cases of the present study also revealed aberrant
karyotypes involving gains at several different chromosomal
regions. Although no specific common aberration was
observed, both cases shared gains at chromosome 7. Losses
of chromosomal regions were not detected. Furthermore, no
chromosomal alterations were shared with the previously
investigated two MIFS [9, 11]. DNA image cytometry
revealed both tumors of our series to be DNA aneuploid,
which has never been investigated so far.
In conclusion, the two MIFS of the present study show
considerable genetic diversity, which is in keeping with the
two previously investigated cases. However, no single
marker or profile of DNA copy number changes character-
izing all tumors could be detected. Further, cytogenetic or
CGH analyses have to be awaited to define specific
cytogenetic profiles of MIFS and possible separate subtypes
of MIFS, respectively.
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